Introduction
Type 2 diabetes is one of the most common endocrine disorders. Across the planet 415 million people have diabetes (1 in 11 adults), estimates are that by 2040 year it will be sick 642 million people, every 6 seconds one person dies from the consequences of diabetes (5 million lethal outcome). The International Federation of Diabetes (IDF) indicated the factors that play a role in development of desease including genetics, lifestyle, environment and diet. The underlying mechanism in the development of type 2 diabetes is insulin resistance and insulin secretion reduced as a result of exhaustion of the beta-cells.
Diabetes mellitus represents a state of chronic hyperglycemia, characterized by disturbed metabolism of carbohydrates, proteins and fats. Occurs due to absolute or relative insulin deficiency, insulin resistance, increased glucose production, and excessive action of the hormones with the opposite effect of insulin. What are the additional contributing factors affecting the occurrence and treatment of this disease, science has so far not clearly defined. What is the basis of the generation of diabetes is not well understood. Therefore, any contribution that leads in this direction is valuable.
The role of insulin antibodies, antibodies to receptors for insulin and vitamin D in the development of diabetes mellitus

Insulin antibodies and insulin receptor antibodies in the onset of diabetes mellitus
In 1950, first described the association between insulin resistance (IR) and insulin antibodies (IA). The presence of IA are then attributed to the use of non-human insulin.
Hypoglycemia simultaneously with the existence of a high titre of insulin antibodies, in patients with diabetes, decribe as autoimmune insulin syndrome or Harate desease 1 . The presence of postprandial hyperglycemia and hypoglycemia fasting, are two of the same process in this disease and are due to binding of insulin antibodies. This insulin antibodies have a low binding affinity for insulin and never lead to IR. 
The role of vitamin D in the development of diabetes
According to many authors, vitamin D plays an important role in controlling blood glucose levels, but also in alleviating chronic diabetic complications. The rationale for this is In a prospective study Jannersjo P et al. 7 investigated the relationship of serum 25(OH)D
and PTH with all-cause mortality in patients with type 2 diabetes and found that in men with type 2 diabetes vitamin D levels inversely correlated with all-cause mortality independently of years, PTH, HbA1c, waist circumference, 24h-monitoring of blood pressure and serum apoB. In women with type 2 diabetes, serum PTH is directly proportional with all causes of death. In this study it was not proven that substitution of vitamin D reduces the risk of mortality, but in spite of this, it was suggested that the serum level of 25(OH)D in men and PTH in women, suffering from type 2 diabetes, can be used as surrogate markers for prognostic information related for mortality. This is an independent risk factor in terms of blood pressure, carotid intima-medial complex (as measured in the carotid artery) and flow rate (measured in the carotid arteries and femoral). Combination therapy with losartan and paricalcitol in diabetic patients, prevent albuminuria, leading restoring glomerular filtration membranes structure and significantly reducing glomerulosclerosis 15 .
Does VDR activators should be used to reduce the progression of CKD still can not be answered with certainty. It takes a larger randomized controlled studies. The reduction of proteinuria in these studies takes place without changes in blood pressure, which indicates that the mechanism of action is nonhaemodinamic. Finally, some meta-analyzes suggest that VDR gene polymorphism may affect individual susceptibility to the development of DN in the white population.
Regarding diabetic retinopathy (DR), calcitriol inhibits angiogenesis in tumours 16 . Diabetic retinopathy is characterized by neovascularisation and the angiogenesis, and high serum That vitamin D deficiency is an independent factor of risk for diabetic retinopathy was confirmed in studies in 1520 patients with type 2 diabetes. In the second study of Jee et al. 19 in 204 patients, statistically significant influence of vitamin D deficiency on diabetic retinopathy was found in male sex, while for females it was not the case. when it comes to the pathophysiological mechanism of the way it performs its activity on target tissues.
Cardio-ankl Vascular Index (CAVI), parameter in the diagnosis of occlusive blood vessel disease
This is a new parameter for determining the rigidity of the artery walls, starting from the aorta to the arteries at the lower extremity joints 22 . The determination of this index is based on beta receptor domination, the effect of the beta 1 receptor on the rigidity of the blood vessels. There is a change in the blood artery caliber and consequently the changes in the internal pressure of the blood vessel 23 . This index is independent of the height of the pressure at that point. Parameters of blood stiffness beta are determined as the ratio of pulse wave velocity and diastolic blood pressure. CAVI is a constant value. Administration of alpha-blockers, which reduce contracture of smooth musculature of arterial wall decrease CAVI value or the blood pressure value. This means that CAVI is the indicator of arteries compliance or vascular function indicator of transport blood from the heart to the peripheral arteries.
Thiazide diuretics and ACE inhibitors, beta 1 blockers, do not reduce CAVI when they reduce the blood pressure.
Parameter of constriction artery beta, is determined over the length of the main arteries. It is calculated by measuring the pulse wave velocity over the brachial artery and arteries of the lower leg at the level of the ankle joint. It is measured systolic and diastolic blood pressure over the brachial artery. The measured values of the application is given in equation. Then he gets a new parameter called Cardio-Ankle-Vascular-Index (CAVI). Figure 1 There is a positive correlation between the value of CAVI and the degree of arteriosclerotic disease. CAVI decreases with improving cardiovascular risk. He is a predictive factor of cardiovascular events. CAVI, at the same time, indirectly represent contracture status of vascular smooth musculature of arterial blood vessels 24, 25 .
When it comes to influence blood glucose level and the value of CAVI, high blood glucose causes contracture of smooth muscles of arteries and increases CAVI in a short period of time. Thereby, reducing HbA1C reduces CAVI, therefore CAVI may be a marker of glucose control. In patients with high LDL cholesterol, it have been shown low CAVI values. In the initial stages of hypercholesterolemia arteries are not rigid, but when in the process of arteriosclerosis include inflammation process then occurs rigidity of blood vessels. Of course, giving statins reduces CAVI. In the pathogenesis of apnea sleepinig, the concentration of high and low oxygen, pass through the walls of blood vessel and contrubute rigidity 26 .
It has been shown that mortality decreased when the CAVI less than 9 in relation to the higher CAVI values. Cerebrovascular events are more common when the CAVI over these values. The results of preliminary studies indicate that it is preferable to CAVI is less or equal 9. It was proven that have been linked value CAVI and diastolic ventricular heart function, and therefore CAVI is indicator of afterload. Or CAVI was determined by compliance of the arterial blood vessel. So, CAVI value increased in: poorly regulated diabetes, obesity, hypertension, infection, cerebral hemorrhage, change in the structure of smooth muscles of the arteries. CAVI is an indicator of the degree artheriosclerosis and degree of contractility of blood vessels 27 .
Role of concentration levels of PAI-1 in the process of angiogenesis and wound healing in diabetes type 2.
PAI-1 has an important role in the local and systemic responses to a trauma, as well as in wound healing. Therefore, points out the importance of the normal levels of PAI-1 in the treatment of tissue ischemia and necrosis of any aetiology. This fact has a bigger role in the patient with diabetes, due to the already present endothelial dysfunction.
It is known that plasminogen affect the wound healing process, the process of the proteolysis of the extracellular matrix, activation of growth factors and activation of cell migration of smooth muscle blood vessel 28, 29 .
As for the role of PAI-1 in wound healing of inflamed tissue in the ischemic type 2 diabetes, it was significantly increased at the early stage of the reaction in the process of neutrophil inflammation. This directly increases the swelling and tissue necrosis. It has been shown that PAI-1 at low concentration has antiapoptotic effect and increases the cell proliferation via its activity and encourages angiogenesis 31, 32 .
Ischemia of lower leg represents a large problem in therapy, but these properties of normal PAI-1 concentration can be used in the treatment of ischemia of diabetics patients. Tissue ischemia itself constitutes a stimulus for the secretion of stem cell transplantation. The angiogenic effect of inhibition of PAI-1, in terms of tissue ischemia, consists in the stimulation of secretion of neutrophilic granulocytes from bone marrow and from tissue.
Produced stimulation of secretion of vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF-2) and the free matrix metalloproteinase (MMP-9) in tissues, increased secretion of angiogenic factors from bone marrow: VEGF, hematopoietic growth factors.
Muscular infiltration with CD11h + Gr1 + neutrophils potentiate the inhibition of PAI-1 by increasing the level of FGF2 and VEGF and thus angiogenesis 33 .
PAI-1 stimulate angiogenesis by increasing FGF receptor on endothelial level, which increases the binding of VEGF to the endothelial cells in ischemic tissue 34, 35 . Thus, FGFs activate VEGF affecting other growth factors and cytokines, which stimulate the development of basic and collateral circulation. tPA mobilise CD11b cells and VEGFR-1 + cells from bone marrow, accelerates healing and neovascularisation of ischemic tissue 36 .
This process indicates that of normal level of concentrations PAI-1 in circulation is another therapeutic approach in the treatment of ischemic tissue in type 2 diabetic patients.
Conclusion
Determination of concentration of vitamin D levels in obese patients, patients with metabolic syndrome and type 2 diabetes is useful, because the concentration of vitamin D in these patients is reduced. An adequate substitution of vitamin D contributes to a better quality of glycemic control. In fasting hypoglycaemia and postprandial hyperglycaemia always overlooked the presence of insulin antibodies and insulin receptor antibody, which substantially impairs the quality of glycemic control in both type 1 and the type 2 diabetes.
Normal concentrations of PAI-1, is another therapeutic approach in the treatment of ischemic tissue in type 2 diabetic patients.
By applying new parameter cardio-ankle vascular index (CAVI), data on early and evolutionary arteriosclerosis could be obtained. Every contribution to the science pointing to all processes in the development of diabetes is valuable in order to clear diagnosis and treatment of this disease.
